Life360, Inc. (LIF) director reports option exercise and share transfer

Rhea-AI Filing Summary

Life360, Inc. director John Coghlan reported an insider transaction involving stock options and common stock. On 12/12/2025, he acquired 920 shares of common stock through the exercise of a stock option with an exercise price of $2.15, reflected with transaction code "M".

After the transaction, he beneficially owns 2,592 shares directly, plus 10,737 shares held by the John Coghlan Living Trust and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust. His derivative holdings include 142,306 stock options. The footnotes state that 1,672 directly held shares were transferred to the John Coghlan Living Trust under an exemption, that 2,592 direct holdings include 1,672 restricted stock units, and that the reported stock option is fully vested and exercisable.

Insider Trade Summary

920 shares exercised/converted

Mixed 4 txns

Insider COGHLAN JOHN PHILIP

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	920	$0.00	--
Exercise	Common stock	920	$2.15	$2K
holding	Common stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 142,306 shares (Direct); Common stock — 2,592 shares (Direct); Common stock — 10,737 shares (Indirect, Held by the John Coghlan Living Trust); Common Stock — 55,494 shares (Indirect, Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust)

Footnotes (1)

1. The Reporting Person transferred 1,672 directly held shares to the John Coghlan Living Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended. Includes 1,672 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. The stock option is fully vested and exercisable.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COGHLAN JOHN PHILIP

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CA 94403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	12/12/2025		M		920	A	$2.15	2,592(1)(2)	D
Common stock								10,737(1)	I	Held by the John Coghlan Living Trust
Common Stock								55,494	I	Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$2.15	12/12/2025		M			920	(3)	10/24/2027	Common stock	920	$0	142,306	D

Explanation of Responses:

1. The Reporting Person transferred 1,672 directly held shares to the John Coghlan Living Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

2. Includes 1,672 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

3. The stock option is fully vested and exercisable.

Remarks:

	/s/ Jay Sood, as Attorney-in-Fact	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Life360 (LIF) director John Coghlan report?

Director John Coghlan reported an insider transaction on 12/12/2025 involving the exercise of a stock option and the acquisition of 920 shares of Life360, Inc. common stock.

How many Life360 (LIF) shares did John Coghlan acquire and at what exercise price?

On 12/12/2025, John Coghlan acquired 920 shares of Life360 common stock through a stock option exercise with an exercise price of $2.15.

How many Life360 (LIF) shares does the director own directly and through trusts after the transaction?

After the reported transaction, John Coghlan beneficially owns 2,592 shares directly, 10,737 shares held by the John Coghlan Living Trust, and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust.

What stock options in Life360 (LIF) does John Coghlan hold following this Form 4 transaction?

Following the transaction, John Coghlan holds 142,306 stock options (rights to buy Life360 common stock). The reported stock option has an exercise price of $2.15 and is described as fully vested and exercisable.

What share transfer to the John Coghlan Living Trust is disclosed for Life360 (LIF)?

The disclosure states that the reporting person transferred 1,672 directly held shares to the John Coghlan Living Trust, and that this transfer was exempt from Section 16 under Rule 16a-13.

What restricted stock units related to Life360 (LIF) are mentioned in the filing?

The explanation notes that the direct holdings include 1,672 restricted stock units, each representing a contingent right to receive one share of Life360 common stock upon vesting.